HOWL Insider L.P. Ra Capital Management Sells $55K of Stock
The firm offloaded 149,625 shares at $0.37 each on June 16, 2026.
Reviewed by automated data checks against the source filing. How we make and check alerts
L.P. Ra Capital Management sold 149,625 shares of Werewolf Therapeutics, Inc. ($HOWL) at an average price of $0.37, worth about $55,361.25, on June 16, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $HOWL is up 0.0% after 1 week, up 2.8% after 1 month and up 172.2% to date (from the $0.36 close on Jun 16, 2026).
HOWL
Werewolf Therapeutics, Inc.
Key Points
- L.P. Ra Capital Management sold 149,625 shares of HOWL on June 16, 2026, at an average price of $0.37 per share.
- HOWL shares were trading around $0.36, with a market cap not provided in the data.
- Analysts maintain a positive outlook on HOWL, with several firms reiterating 'buy' ratings and targets as high as $15.
Get $HOWL trade alerts by text
We text you when insiders, Congress or big funds trade $HOWL. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Werewolf Therapeutics, Inc. alert may contain errors. Disclosures
L.P. Ra Capital Management sold 149,625 shares of HOWL on June 16, 2026, at an average price of $0.37 per share. This transaction was not part of a pre-planned trading scheme and reflects the firm's recent activity in the stock.
What Changed in L.P. Ra Capital Management's HOWL Position
The sell-off by L.P. Ra Capital Management involved 149,625 shares of HOWL, valued at approximately $55,361. This move comes amid several similar transactions by the firm over the previous week.
Other Institutional Activity in HOWL
RA Capital Management, L.P. maintained its position with 6,681,307 shares valued at about $5,562,856. Vanguard Capital Management LLC significantly increased its holdings by 1,217,976 shares, bringing its total to 1,217,976 shares worth roughly $1,014,574. MPM BioImpact LLC reduced its stake by 184,747 shares, ending with 1,208,810 shares valued at approximately $1,006,455. Lynx1 Capital Management LP slightly increased its position by 1,860 shares, totaling 657,786 shares with a value of $547,673.
Werewolf Therapeutics, Inc. Stock Down 62.7%
Shares of HOWL were trading near $0.36. However, detailed financial metrics such as market cap, P/E ratio, and other valuation measures were not provided in the available data.
Insider Buying and Selling at Werewolf Therapeutics, Inc.
L.P. Ra Capital Management executed several sales in June 2026. On June 16, it sold 149,625 shares at $0.37 each. Earlier, on June 15, it sold 128,770 shares at $0.39 per share. On June 12, the firm sold 170,441 shares at $0.40, and on June 11, it sold 262,503 shares at $0.38. The selling spree continued on June 10 and June 9, with transactions of 45,923 and 369,800 shares at $0.37 each, respectively. None of these sales were part of a 10b5-1 trading plan.
Analysts Set New Price Targets
Analysts have been maintaining a positive outlook on HOWL. On December 19, 2025, HC Wainwright & Co. maintained a 'buy' rating with a $4 price target. B of A Securities also maintained its 'buy' rating, setting a target of $7 on November 18, 2025. Earlier in the year, JMP Securities and Wedbush reiterated their 'buy' ratings with price targets of $3 and $6, respectively.
Bottom Line
L.P. Ra Capital Management's recent sales of HOWL shares highlight ongoing adjustments in its portfolio. Investors often watch such insider activities closely for potential market signals, although these transactions alone do not necessarily indicate a negative outlook. Analyst ratings remain positive, suggesting continued interest in the company's future performance.
Related Filing Alerts
Source: L.P. Ra Capital Management's Form 4 filing on $HOWL (Jun 16, 2026). Find the original filing: HOWL Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts